Masashi Tabuchi1, Shahnaz R Lone1, Sha Liu1, Qili Liu1, Julia Zhang1, Adam P Spira2, Mark N Wu3. 1. Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA. 2. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. 3. Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA; Department of Neuroscience, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: marknwu@jhmi.edu.
Abstract
BACKGROUND: Emerging data suggest an important relationship between sleep and Alzheimer's disease (AD), but how poor sleep promotes the development of AD remains unclear. RESULTS: Here, using a Drosophila model of AD, we provide evidence suggesting that changes in neuronal excitability underlie the effects of sleep loss on AD pathogenesis. β-amyloid (Aβ) accumulation leads to reduced and fragmented sleep, while chronic sleep deprivation increases Aβ burden. Moreover, enhancing sleep reduces Aβ deposition. Increasing neuronal excitability phenocopies the effects of reducing sleep on Aβ, and decreasing neuronal activity blocks the elevated Aβ accumulation induced by sleep deprivation. At the single neuron level, we find that chronic sleep deprivation, as well as Aβ expression, enhances intrinsic neuronal excitability. Importantly, these data reveal that sleep loss exacerbates Aβ-induced hyperexcitability and suggest that defects in specific K(+) currents underlie the hyperexcitability caused by sleep loss and Aβ expression. Finally, we show that feeding levetiracetam, an anti-epileptic medication, to Aβ-expressing flies suppresses neuronal excitability and significantly prolongs their lifespan. CONCLUSIONS: Our findings directly link sleep loss to changes in neuronal excitability and Aβ accumulation and further suggest that neuronal hyperexcitability is an important mediator of Aβ toxicity. Taken together, these data provide a mechanistic framework for a positive feedback loop, whereby sleep loss and neuronal excitation accelerate the accumulation of Aβ, a key pathogenic step in the development of AD.
BACKGROUND: Emerging data suggest an important relationship between sleep and Alzheimer's disease (AD), but how poor sleep promotes the development of AD remains unclear. RESULTS: Here, using a Drosophila model of AD, we provide evidence suggesting that changes in neuronal excitability underlie the effects of sleep loss on AD pathogenesis. β-amyloid (Aβ) accumulation leads to reduced and fragmented sleep, while chronic sleep deprivation increases Aβ burden. Moreover, enhancing sleep reduces Aβ deposition. Increasing neuronal excitability phenocopies the effects of reducing sleep on Aβ, and decreasing neuronal activity blocks the elevated Aβ accumulation induced by sleep deprivation. At the single neuron level, we find that chronic sleep deprivation, as well as Aβ expression, enhances intrinsic neuronal excitability. Importantly, these data reveal that sleep loss exacerbates Aβ-induced hyperexcitability and suggest that defects in specific K(+) currents underlie the hyperexcitability caused by sleep loss and Aβ expression. Finally, we show that feeding levetiracetam, an anti-epileptic medication, to Aβ-expressing flies suppresses neuronal excitability and significantly prolongs their lifespan. CONCLUSIONS: Our findings directly link sleep loss to changes in neuronal excitability and Aβ accumulation and further suggest that neuronal hyperexcitability is an important mediator of Aβ toxicity. Taken together, these data provide a mechanistic framework for a positive feedback loop, whereby sleep loss and neuronal excitation accelerate the accumulation of Aβ, a key pathogenic step in the development of AD.
Authors: Anna Scalise; Maria Teresa Desiato; Gian Luigi Gigli; Andrea Romigi; Mario Tombini; Maria Grazia Marciani; Francesca Izzi; Fabio Placidi Journal: Sleep Date: 2006-12 Impact factor: 5.849
Authors: Koichi Iijima; Hsin-Ping Liu; Ann-Shyn Chiang; Stephen A Hearn; Mary Konsolaki; Yi Zhong Journal: Proc Natl Acad Sci U S A Date: 2004-04-06 Impact factor: 11.205
Authors: Calliope Holingue; Alexandra Wennberg; Slava Berger; Vsevolod Y Polotsky; Adam P Spira Journal: Metabolism Date: 2018-02-01 Impact factor: 8.694
Authors: Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble Journal: Eur J Neurosci Date: 2019-01-29 Impact factor: 3.386
Authors: Belinda M Brown; Hamid R Sohrabi; Kevin Taddei; Samantha L Gardener; Stephanie R Rainey-Smith; Jeremiah J Peiffer; Chengjie Xiong; Anne M Fagan; Tammie Benzinger; Virginia Buckles; Kirk I Erickson; Roger Clarnette; Tejal Shah; Colin L Masters; Michael Weiner; Nigel Cairns; Martin Rossor; Neill R Graff-Radford; Stephen Salloway; Jonathan Vöglein; Christoph Laske; James Noble; Peter R Schofield; Randall J Bateman; John C Morris; Ralph N Martins Journal: Alzheimers Dement Date: 2017-05-11 Impact factor: 21.566
Authors: Adam P Spira; Yang An; Mark N Wu; Jocelynn T Owusu; Eleanor M Simonsick; Murat Bilgel; Luigi Ferrucci; Dean F Wong; Susan M Resnick Journal: Sleep Date: 2018-10-01 Impact factor: 5.849
Authors: Breton M Asken; Molly J Sullan; Aliyah R Snyder; Zachary M Houck; Vaughn E Bryant; Loren P Hizel; Molly E McLaren; Duane E Dede; Michael S Jaffee; Steven T DeKosky; Russell M Bauer Journal: Neuropsychol Rev Date: 2016-08-25 Impact factor: 7.444
Authors: Adam P Spira; Christopher E Gonzalez; Vijay K Venkatraman; Mark N Wu; Jennifer Pacheco; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick Journal: Sleep Date: 2016-05-01 Impact factor: 5.849